EquasensFRA:PHF 98 FCF Yield % is 8.92 as of Jun. 28, 2026, which is 199% above its 10-year median of 2.98. GuruFocus rates FRA:PHF with a GF Score™ of 98/100 and a GF Value™ of €85.23. The stock has 2 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Equasens ranks better than 79.36% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Equasens's FCF Yield % or its related term are showing as below:
FRA:PHF'
s FCF Yield % Range Over the Past 10 Years
Min: 1.4 Med: 2.98 Max: 9.09
Current: 8.92
During the past 13 years, the highest FCF Yield % of Equasens was 9.09%. The lowest was 1.40%. And the median was 2.98%.
FRA:PHF's FCF Yield % is ranked better than 79.36% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.88
vs FRA:PHF: 8.92
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Equasens FCF Yield % Related Terms
Equasens FCF Yield % Historical Data
* Premium members only.
The historical data trend for Equasens's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PHF vs VEEV, BTSG, TEM: FCF Yield % Comparison
For the Health Information Services subindustry, Equasens's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Equasens FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Equasens's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Equasens's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equasens (FRA:PHF) has a FCF Yield % of 8.92 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Equasens and its competitors. This is 199% above median its historical median of 2.98. Over the past decade, Equasens' FCF Yield % has ranged from 1.40 to 9.09. According to the industry distribution chart, Equasens ranks #141 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 20.6%.
Is Equasens' FCF Yield % too high?
Equasens' current FCF Yield % of 8.92 is 199% above median its 10-year median of 2.98. Over the past 10 years, this metric has ranged from a low of 1.40 to a high of 9.09. The Healthcare Providers & Services industry median FCF Yield % is 1.88. Equasens' value of 8.92 is 374.5% above this industry median. Based on the distribution chart, Equasens ranks #141 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Equasens has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Equasens' FCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Equasens ranks #141 out of 683 companies for FCF Yield %. This places Equasens in the top 21% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.88. Equasens' value of 8.92 is 374.5% above this benchmark. Historically, Equasens' own FCF Yield % has ranged from 1.40 to 9.09 over the past decade. While the company's 10-year median is 2.98 vs. the industry median of 1.88, Equasens has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.88, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Equasens's current FCF Yield % of 8.92 is 374.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Equasens and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Equasens's current FCF Yield % is 8.92, which is 199% above median its own 10-year median of 2.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Equasens stock overvalued right now?
Equasens (FRA:PHF) has a current FCF Yield % of 8.92. The stock's GF Value™ is €85.23, compared to a current price of €52.77 — trading 38.1% below its estimated fair value. The current FCF Yield % is 8.92, which is 199% above median its 10-year median of 2.98 and 374.5% above the Healthcare Providers & Services industry median of 1.88. Equasens' overall GF Score™ is 98/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Equasens (FRA:PHF), the current FCF Yield % is 8.92 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Equasens (FRA:PHF) Overvalued in 2026?
Based on GuruFocus' analysis, Equasens stock appears to be undervalued.
The current stock price of €52.77 is trading 38.1% below its estimated GF Value™ of €85.23.
Key valuation signals for FRA:PHF:
FCF Yield %: 8.92 (199% above median its 10-year median of 2.98)
GF Value™: €85.23 vs. price of €52.77 (38.1% below fair value)
Industry Position: 374.5% above the Healthcare Providers & Services median (#141 of 683)
No single metric tells the full story. See the FRA:PHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centers) and patients in both primary and secondary care sectors. The various activities that the company is involved in include: pharmacy software publishing and integration, publishing of IT solutions for health and medical/social establishments, and development of solutions and infrastructures for e-Health. With operations in France (its key revenue-generating market), Italy, Belgium, Germany, Ireland, and the United Kingdom, it is developing the healthcare platform and an ecosystem in France and Europe, benefiting people by making its technology services available.
98GF Score
Get the complete analysis for FRA:PHF
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PHF has been successfully added to your 
